Efectos adversos a corto plazo de dexametasona posnatal con dosis bajas para fines de extubación

Perinatología y Reproducción Humana - Tập 30 - Trang 138-142 - 2016
E. Yllescas Medrano1, B. López Valle1, L.A. Fernández Carrocera1, G. Cordero González1, S. Carrera Muiños1
1Unidad de Cuidados Intensivos Neonatales, Instituto Nacional de Perinatología, Ciudad de México, México

Tài liệu tham khảo

Merritt, 2009, The “new” broncopulmonary dysplasia: Challenges and commentary, Semin Fetal Neonatal Med., 14, 345, 10.1016/j.siny.2009.08.009 Shennan, 1988, Abnormal pulmonary outcomes in premature infants: Predictions from oxygen requirement in the neonatal period, Pediatrics, 82, 527, 10.1542/peds.82.4.527 Gregoire, 1998, Health and development outcomes at 18 months in very preterm infants with bronchopulmonary dysplasia, Pediatrics, 101, 856, 10.1542/peds.101.5.856 Bancalari, 2001, Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Review article, Am J Perinatol, 18, 1, 10.1055/s-2001-12940 Van Marter, 2009, Epidemiology of bronchopulmonary dysplasia, Semin Fetal Neonatal Med., 14, 358, 10.1016/j.siny.2009.08.007 Farell, 1997, Bronchopulmonary dysplasia in the 1990s: A review for the pediatrician, Curr Probl Pediatr., 27, 129, 10.1016/S0045-9380(97)80017-5 Ballabh, 2003, Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone, Pediatr Pulmonol, 35, 392, 10.1002/ppul.10279 Laughon, 2009, Prevencion of bronchopulmonary dysplasia, Semin Fetal Neonatal Med, 14, 374, 10.1016/j.siny.2009.08.002 Cummings, 1989, A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia, N Engl J Med, 320, 1505, 10.1056/NEJM198906083202301 Durand, 1995, Effect of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: A randomised controlled trial, Pediatrics, 95, 584, 10.1542/peds.95.4.584 Kari, 1993, Dexamethasone treatmen in preterm infants at risk for bronchopulmonary dysplasia, Arch Dis Child, 68, 566, 10.1136/adc.68.5_Spec_No.566 Brozansky, 1995, Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant, J Pediatr, 126, 769, 10.1016/S0022-3476(95)70410-8 Kovacs, 1998, Efficacy of sequential early systemic and inhaled corticosteroid teraphy in the prevention of chronic lung disease of prematurity, Acta Pediatr, 87, 792, 10.1111/j.1651-2227.1998.tb01749.x Papile, 1998, A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants, N Engl J Med, 338, 1112, 10.1056/NEJM199804163381604 Romagnoli, 1998, II dezametazone nella prevenzione della patología pulmonare crónica del neonato pretermina: studio prosperttico randomizzato, Riv Ital Pediatr., 24, 283 Yates, 2011, Minidex: Very low dose dexametasone (0.05mg/k/day) in chronic lung disease, Arch Dis Child Fetal Neonatal, 191 American Academy of Pediatrics–Canadian Pediatric Society. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics. 2002; 109: 330-8. Ohlsson, 1992, A randomized controlled trial of dexamethasone treatment in very low birth weight infants, Act pediatr., 81, 751, 10.1111/j.1651-2227.1992.tb12096.x Jones, 1995, Controlled trial of dexamethasone in neonatal chronic lung disease: A 3 years follow-up Pediatrics, 96, 897 VIncer, 1998, Double blind controlled trial of 6 day pulse of dexametasone for very low birth weight infants, who are ventilador dependent at 4 weeks of age, Pediatr Res, 43, 201A, 10.1203/00006450-199804001-01195 Sankar, 2008, Chronic lung disease in newborns, Indian J Pediatr, 75, 369, 10.1007/s12098-008-0041-6 Halliday, 2003, Early postnatal (<96hours) corticosteroids for preventing chronic lung disease in preterm infants, Cochrane Database Syst Rev., 1 Halliday, 2003, Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants, Cochrane Database Syst Rev., 1 Andla, 2003, Steroid therapy in the high-risk neonate: Benefits and risks, Clin Obstet Gynecol, 46, 190, 10.1097/00003081-200303000-00022 Stark, 2001, Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network, N Engl J Med, 344, 95, 10.1056/NEJM200101113440203